Literature DB >> 6290963

Dental analgesia produced by non-painful low-frequency stimulation is not influenced by stress or reversed by naloxone.

Antti Pertovaara1, Pentti Kemppainen, Gunnar Johansson, Sirkka-Liisa Karonen.   

Abstract

The dental pain threshold elevation produced by non-painful, low-frequency transcutaneous electrical nerve stimulation (TENS) in healthy humans was not reduced by the administration of 0.8 mg of naloxone i.v. Neither ACTH, prolactin nor growth hormone (GH) release were related to the pain threshold elevations. The present study indicates that the dental pain threshold elevation during non-painful, low-frequency TENS is not based on the same opioid-dependent mechanisms as the dental pain threshold elevation during acupuncture or the clinical analgesia during low-frequency TENS. Stress or other adenohypophyseal mechanisms involving ACTH, prolactin or GH do not explain the analgesia induced by non-painful, low-frequency TENS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290963     DOI: 10.1016/0304-3959(82)90006-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  4 in total

1.  Evaluation of low-intensity transcutaneous electrical nerve stimulation in combination with aspirin for reduction of controlled thermal sensation.

Authors:  K C Kajander
Journal:  Anesth Prog       Date:  1988 Sep-Oct

2.  Thermal sensitivity is not changed by acute pain or afferent stimulation.

Authors:  A Ekblom; P Hansson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

3.  Effect of peripheral electrical stimulation on measures of tooth pain threshold and oral soft tissue comfort in children.

Authors:  S M Abdulhameed; R J Feigal; J D Rudney; K C Kajander
Journal:  Anesth Prog       Date:  1989 Mar-Apr

Review 4.  Endogenous opioid antagonism in physiological experimental pain models: a systematic review.

Authors:  Mads U Werner; Manuel P Pereira; Lars Peter H Andersen; Jørgen B Dahl
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.